PM
64
-6
HCP
56
4
FAST
46
2
WEC
34
-2
V
60
-6
AME
69
3
ACN
47
-5
MNST
54
4
MSFT
67
3
FLR
52
3
SIG
79
3
KEY
33
2
PYPL
43
-6
NWSA
80
2
MCK
73
-2
AN
55
5
AIV
57
3
MRO
47
9
MSI
57
2
COP
39
-3
PM
64
-6
HCP
56
4
FAST
46
2
WEC
34
-2
V
60
-6
AME
69
3
ACN
47
-5
MNST
54
4
MSFT
67
3
FLR
52
3
SIG
79
3
KEY
33
2
PYPL
43
-6
NWSA
80
2
MCK
73
-2
AN
55
5
AIV
57
3
MRO
47
9
MSI
57
2
COP
39
-3
Financhill
Back

Skye Bioscience Quote, Financials, Valuation and Earnings

Sell
29

SKYE
Skye Bioscience

Last Price:
10.79
Seasonality Move:
-18.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Skye Bioscience Price Quote

$10.79
+0.60 (+5.89%)
(Updated: June 13, 2024 at 6:55 PM ET)

Skye Bioscience Key Stats

Sell
29
Skye Bioscience (SKYE) is a Sell
Day range:
$9.75 - $10.42
52-week range:
$1.44 - $19.41
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
457.49
P/B ratio:
3.63%
Volume:
455.2K
Avg. volume:
115.7K
1-year change:
157.16%
Market cap:
$286M
Revenue:
$0
EPS:
$-4.51

How Much Does Skye Bioscience Make?

Data Unavailable

Is Skye Bioscience Growing As A Company?

Data Unavailable

Skye Bioscience Stock Price Performance

  • Did Skye Bioscience Stock Go Up Last Month?
    Skye Bioscience share price went down by -9.98% last month
  • Did SKYE's Share Price Rise Over The Last Year?
    SKYE share price rose by 157.16% over the past 1 year

What Is Skye Bioscience 52-Week High & Low?

Skye Bioscience Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Skye Bioscience?

  • How Much Debt Does Skye Bioscience Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Skye Bioscience Have?
    Cash and short term investments quarterly total is $83.3M
  • What Is Skye Bioscience’s Book Value Per Share?
    Book value per share is 2.81

Is Skye Bioscience Cash Flow Positive?

  • What Is SKYE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$14.6M
  • What Is Skye Bioscience’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $102.1M
  • What Is Skye Bioscience’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $2.2M

Skye Bioscience Return On Invested Capital

Data Unavailable

Skye Bioscience Earnings Date & Stock Price

Skye Bioscience Competitors

  • Who Are Skye Bioscience's Competitors?
    Below is a list of companies who compete with Skye Bioscience or are related in some way:
    • Cutera Inc (CUTR)
    • OrthoPediatrics Corp (KIDS)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • RAPT Therapeutics Inc (RAPT)

Skye Bioscience Dividend Yield

Data Unavailable

Skye Bioscience Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -12.5%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 18.33
Upside from Last Price: 79.91%

Major Shareholders

  • How many SKYE shares are owned by institutional investors?
    505.4M SKYE shares are owned by institutional investors
  • How many SKYE shares are owned by insiders?
    8.1M SKYE shares are owned by insiders